Progression of mild cognitive impairment to Alzheimer's disease: Improved diagnostic value of the combined use of N200 latency and β-amyloid(1-42) levels

Dementia and Geriatric Cognitive Disorders

Volumn 28, Issue 1, 2009, Pages 30-35

  Papaliagkas, V T ^a   Anogianakis, G ^a   Tsolaki, M N ^a   Koliakos, G ^a   Kimiskidis, V K ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Amyloid(1 42); Alzheimer's disease; Auditory event related potentials; Mild cognitive impairment; N200 latency

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; BRAIN PROTEIN;

AGED; ALZHEIMER DISEASE; AMPLITUDE MODULATION; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; ELECTROPHYSIOLOGY; EVOKED AUDITORY RESPONSE; FEMALE; FOLLOW UP; HUMAN; LATENT PERIOD; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BIOLOGICAL MARKERS; COGNITION DISORDERS; DISCRIMINATION (PSYCHOLOGY); DISEASE PROGRESSION; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS;

EID: 67651006541     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000229023     Document Type: Article

References (24)

1. Andreasen N, Blennow K: CSF biomarkers for mild cognitive impairment and early Alzheimer's disease. Clin Neurol Neurosurg 2005;107:165-173. (Pubitemid 40502220)
2. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944. (Pubitemid 14076461)
3. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Müller-Hill B: The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987;325:733-736. (Pubitemid 17054046)
4. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K: Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985;82:4245-4249. (Pubitemid 15053619)
5. Strozyk D, Blennow K, White LR, Launer LJ: CSF Ab42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 2003;60:652-656. (Pubitemid 36246085)
6. Andreasen N, Hesse C, Davidsson P, Min thon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K: Cerebrospinal fluid β-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol 1999;56:673-680.
7. Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss MA, Seubert P: High cerebrospinal fluid tau and low amyloid β42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol 1998;55:937-945. (Pubitemid 28335112)
8. Hampel H, Teipel SJ, Fuchsberger T, Andreasen N, Wiltfang J, Otto M, Shen Y, Dodel R, Du Y, Farlow M, Möller HJ, Blennow K, Buerger K: Value of CSF β-amyloid 1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment. Mol Psychiatry 2004;9:705-710. (Pubitemid 38932175)
9. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L: Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006;5:228-234. (Pubitemid 43238346)
10. Bennys K, Portet F, Touchon J, Rondouin G: Diagnostic value of event-related evoked potentials N200 and P300 subcomponents in early diagnosis of Alzheimer's disease and mild cognitive impairment. J Clin Neurophysiol 2007;24:405-412. (Pubitemid 47524880)
11. Papaliagkas VT, Kimiskidis VK, Tsolaki MN, Anogianakis G: Usefulness of event-related potentials in the assessment of mild cognitive impairment. BMC Neurosci 2008;9:107.
12. Banquet JP, Guenther W, Smith M: Probability processing in depressed patients. Electroencephalogr Clin Neurophysiol Suppl 1987;40:645-650.
13. Alho K: Cerebral generators of mismatch negativity (MMN) and its magnetic counterpart (MMNm) elicited by sound changes. Ear Hear 1995;16:38-51.
14. Potts GF, Dien J, Hartry-Speiser AL, McDougal LM, Tucker DM: Dense sensor array topography of the event-related potential to task-relevant auditory stimuli. Electroencephalogr Clin Neurophysiol 1998;106:444-456. (Pubitemid 28238237)
15. Piras MR, Magnano I, Canu ED, Paulus KS, Satta WM, Soddu A, Conti M, Achene A, Solinas G, Aiello I: Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. J Neurol Neurosurg Psychiatry 2003;74:878-885. (Pubitemid 36782987)
16. Folstein M, Folstein S, McHugh P: 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
17. Fountoulakis K, Tsolaki M, Chantzi H, Kazis A: Mini-Mental State Examination (MMSE): a validation study in the Greek elderly population. Encephalos (Greece) 1994;31:93-102.
18. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308. (Pubitemid 29120227)
19. Schoonenboom SN, Visser PJ, Mulder C, Lindeboom J, Van Elk EJ, Van Kamp GJ, Scheltens PH: Biomarker profiles and their relation to clinical variables in mild cognitive impairment. Neurocase 2005;11:8-13. (Pubitemid 40372855)
20. Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB: Progression to dementia in patients with isolated memory loss. Lancet 1997;349:763-765. (Pubitemid 27122459)
21. Petersen RC: Mild cognitive impairment clinical trials. Nat Rev Drug Discov 2003;2:646-653. (Pubitemid 37361768)
22. Missonnier P, Deiber MP, Gold G, Herrmann FR, Millet P, Michon A, Fazio-Costa L, Ibañez V, Giannakopoulos P: Working memory load-related electroencephalographic parameters can differentiate progressive from stable mild cognitive impairment. Neuroscience 2007;150:346-356. (Pubitemid 350198709)
23. Papaliagkas VT, Anogianakis GA, Tsolaki MN, Koliakos G, Kimiskidis VK: Prediction of conversion from mild cognitive impairment to Alzheimer's disease by CSF cytochrome c levels and N200 latency. Curr Alzheimer Res 2009;6:276-284.
24. Allison T, Puce A, McCarthy G: Category-sensitive excitatory and inhibitory processes in human extrastriate cortex. J Neurophysiol 2002;88:2864-2868. (Pubitemid 35346082)